A detailed history of Gts Securities LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Gts Securities LLC holds 121,900 shares of MRK stock, worth $13.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
121,900
Previous 189,400 35.64%
Holding current value
$13.9 Million
Previous $25 Million 39.61%
% of portfolio
0.03%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $3.12 Million - $3.35 Million
25,218 Added 847.38%
28,194 $3.49 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $4.45 Million - $5.18 Million
-39,277 Reduced 92.96%
2,976 $392,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $3.57 Million - $3.88 Million
35,623 Added 537.3%
42,253 $4.61 Million
Q3 2023

Nov 15, 2023

BUY
$102.95 - $114.33 $682,558 - $758,007
6,630 New
6,630 $682,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $288B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.